Conquer Aging: Predicting Heart Disease Risk With ApoB, LP(a), and VLDL
Peer-Reviewed Research
Key Takeaways
- Test ApoB levels to accurately assess heart disease risk, as it measures the number of atherogenic particles.
- Monitor LP(a) levels, as elevated levels significantly increase cardiovascular risk.
- Track VLDL particles to understand triglyceride-rich lipoprotein contribution to heart disease.
- Combine lipid panel with these markers for a comprehensive heart disease risk assessment.
Bottom Line
Include ApoB, LP(a), and VLDL testing in your routine lipid panel to better predict and manage your heart disease risk.
Explore More
- Conquer Aging’s Full Protocol — supplements, dosages, and daily routine
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network
